Skip to main content
Premium Trial:

Request an Annual Quote

Pall s New Center of Excellence in Bangalore Will Have Proteomics Component

 NEW YORK, March 21 (GenomeWeb News) -

Pall has opened a Center of Excellence in Bangalore, India, that will include a process proteomics lab for chromatography and down-stream systems, Pall said today.

 

The center will also offer clients validation services for FDA approval.

 

"The process proteomics facility is a service to our customers," said Holly Haughney, vice president of Pall BioPharmaceuticals Marketing Asia. "In addition, we will have a training facility because while there is a very well-educated technical force [in India], we've found that much of it is theoretical."

 

Haughney recently relocated to the Bangalore office, along with Vinay Joban, general manager of Pall Life Sciences India.

 

Pall's biopharm business in Asia grew by 14 percent over the last fiscal year, the company said in a statement.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.